# Ardent Health, Inc. (ARDT) FY2026 YTD Q2 P&L / Income Statement

- Company: Ardent Health, Inc. (ARDT)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-10, accession number 0001628280-26-055215
- Page: https://plicit.ai/financials/ardt/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/ardt-fy2026-ytd-q2-income-statement-sankey.png

## Chart details

Income statement for 2026-01-01 through 2026-06-30. View: Product and Service by Health Care Organization, Revenue Sources. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 3,224,115,000 US dollars
- **Cost of revenue (calculated)**: 84,328,000 US dollars
- **Gross profit (calculated)**: 3,139,787,000 US dollars
- **Operating expenses (calculated)**: 3,021,993,000 US dollars
- **Operating profit (calculated)**: 117,794,000 US dollars
- **Other income (expense), net (calculated)**: 0 US dollars
- **Income before income taxes**: 117,794,000 US dollars
- **Income tax expense**: 24,617,000 US dollars
- **Net income**: 93,177,000 US dollars
- **Medicaid - Third-Party Payor**: 318,501,000 US dollars
- **Medicare - Third-Party Payor**: 1,320,712,000 US dollars
- **Other managed care - Third-Party Payor**: 1,373,012,000 US dollars
- **Self-pay and other - Third-Party Payor**: 167,611,000 US dollars
- **Undisclosed (calculated)**: 44,279,000 US dollars
- **Depreciation and amortization**: 84,328,000 US dollars
- **Salaries and benefits**: 1,337,617,000 US dollars
- **Professional fees**: 644,913,000 US dollars
- **Supplies**: 548,174,000 US dollars
- **Rents and leases**: 132,410,000 US dollars
- **Other operating expenses**: 339,989,000 US dollars
- **Interest expense**: 24,780,000 US dollars
- **Other non-operating losses (gains)**: negative 5,890,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to Ardent Health, Inc.: $56.75 M; to noncontrolling interests: $36.43 M.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/ardt/fy2026-ytd-q2-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/ardt-fy2026-ytd-q2-revenue-by-geography-sankey.png

Income statement for 2026-01-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 3,224,115,000 US dollars
- **Cost of revenue (calculated)**: 84,328,000 US dollars
- **Gross profit (calculated)**: 3,139,787,000 US dollars
- **Operating expenses (calculated)**: 3,021,993,000 US dollars
- **Operating profit (calculated)**: 117,794,000 US dollars
- **Other income (expense), net (calculated)**: 0 US dollars
- **Income before income taxes**: 117,794,000 US dollars
- **Income tax expense**: 24,617,000 US dollars
- **Net income**: 93,177,000 US dollars
- **Other (calculated)**: 438,479,640 US dollars
- **New Jersey (calculated)**: 332,083,845 US dollars
- **New Mexico (calculated)**: 577,116,585 US dollars
- **Oklahoma (calculated)**: 738,322,335 US dollars
- **Texas (calculated)**: 1,138,112,595 US dollars
- **Depreciation and amortization**: 84,328,000 US dollars
- **Salaries and benefits**: 1,337,617,000 US dollars
- **Professional fees**: 644,913,000 US dollars
- **Supplies**: 548,174,000 US dollars
- **Rents and leases**: 132,410,000 US dollars
- **Other operating expenses**: 339,989,000 US dollars
- **Interest expense**: 24,780,000 US dollars
- **Other non-operating losses (gains)**: negative 5,890,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to Ardent Health, Inc.: $56.75 M; to noncontrolling interests: $36.43 M.